Results 261 to 270 of about 99,250 (279)
Some of the next articles are maybe not open access.
Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns
Nature MedicineThe first vaccine against chikungunya virus (CHIKV) has now been licensed; however, due to a limited knowledge of the underlying global burden, its potential to reduce disease burden remains unknown.
Gabriel Ribeiro dos Santos +15 more
semanticscholar +1 more source
BioDrugs
Chikungunya virus is an emerging mosquito-borne alphavirus that causes febrile illness and arthritic disease. Chikungunya virus is endemic in 110 countries and the World Health Organization estimates that it has caused more than 2 million cases of ...
W. Weber, D. Streblow, Lark L. Coffey
semanticscholar +1 more source
Chikungunya virus is an emerging mosquito-borne alphavirus that causes febrile illness and arthritic disease. Chikungunya virus is endemic in 110 countries and the World Health Organization estimates that it has caused more than 2 million cases of ...
W. Weber, D. Streblow, Lark L. Coffey
semanticscholar +1 more source
From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine
Journal of Travel MedicineBackground Over the past 20 years, over 5 million cases of chikungunya, a mosquito-transmitted viral disease, have been reported in over 110 countries.
Lin H Chen +4 more
semanticscholar +1 more source
Biology and pathogenesis of chikungunya virus
Nature Reviews Microbiology, 2010Olivier Schwartz, Matthew L Albert
exaly
FHL1 is a major host factor for chikungunya virus infection
Nature, 2019Laurent Meertens +2 more
exaly
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Lancet, The, 2007R Angelini
exaly
Vaccine and Therapeutic Options To Control Chikungunya Virus
Clinical Microbiology Reviews, 2018Ann M Powers
exaly
Controlling vector-borne diseases by releasing modified mosquitoes
Nature Reviews Microbiology, 2018Heather A Flores, Scott L O'neill
exaly

